Want to see TSE:NDAT full AI Analyst Report?
NDAT Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.20
Previous CloseN/A
Volume91.00K
Average Volume (3M)0.00
Market Cap
C$2.89M
Enterprise ValueC$2.39M
Total Cash (Recent Filing)C$499.07K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding41,327,423
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)6.95
Price to Sales (P/S)60.55
P/FCF Ratio-26.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA zero-debt structure materially reduces solvency risk and gives management flexibility to fund operations or strategic initiatives without immediate interest burden. Over 2-6 months this lower fixed-cost profile preserves optionality for financing, partnerships, or restructuring while cash burn is addressed.
High Recent Gross MarginElevated gross margins indicate the core software/data product has favorable incremental economics and potential for scalability. If nDatalyze can stabilize demand, high gross margins allow operating leverage to flow to profitability over time as fixed R&D and SG&A are absorbed, supporting durable margin recovery.
Recurring Licensing/subscription ModelA subscription/licensing business creates durable, predictable revenue and customer retention opportunities, improving lifetime value versus one-off sales. This model supports scaling, cross-sell with clinical partners, and recurring cash generation potential if customer acquisition stabilizes, aligning with long-term value creation.
Bears Say
Revenue CollapseA multi-year, near-total revenue decline erodes the company’s ability to leverage fixed costs and sustain critical operations. Over months this structural revenue failure undermines partner confidence, limits reinvestment capacity, and makes achieving break-even or scaling the subscription model materially more difficult without a clear demand turnaround.
Persistent Negative Cash FlowSustained operating and free cash flow deficits necessitate external funding and constrain operational choices. Over 2-6 months this cash burn risks dilution from equity raises, curtailed R&D or sales investment, and increased dependency on capital markets or partners, limiting strategic execution and continuity without financing.
Equity Erosion From Sustained LossesSignificant decline in equity reflects cumulative losses that reduce the balance-sheet buffer against shocks and limit leverage options. Over the medium term this weakens financial resilience, increases the likelihood of dilutive capital raises, and can constrain partnerships or vendor terms that depend on strong capitalization.
nDatalyze Corp News
NDAT FAQ
What was nDatalyze Corp’s price range in the past 12 months?
nDatalyze Corp lowest stock price was C$0.01 and its highest was C$0.20 in the past 12 months.
What is nDatalyze Corp’s market cap?
nDatalyze Corp’s market cap is C$2.89M.
When is nDatalyze Corp’s upcoming earnings report date?
nDatalyze Corp’s upcoming earnings report date is Jul 23, 2026 which is in 18 days.
How were nDatalyze Corp’s earnings last quarter?
Currently, no data Available
Is nDatalyze Corp overvalued?
According to Wall Street analysts nDatalyze Corp’s price is currently Overvalued.
Does nDatalyze Corp pay dividends?
nDatalyze Corp does not currently pay dividends.
What is nDatalyze Corp’s EPS estimate?
nDatalyze Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does nDatalyze Corp have?
nDatalyze Corp has 41,327,423 shares outstanding.
What happened to nDatalyze Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of nDatalyze Corp?
Currently, no hedge funds are holding shares in TSE:NDAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
nDatalyze Corp
nDatalyze Corp., established in 2018 and based in Calgary, Canada, specializes in developing innovative technology-driven solutions for the health sector. Its current primary focus includes the creation of an online mental health application for consumers, leveraging machine learning, alongside offering data licensing services. Additionally, the company manufactures and supplies specialized equipment for CO2 and alcohol-based essential oil extraction, catering primarily to medical cannabis cultivators. The organization adopted its current name in October 2021, having previously operated as MedXtractor Corp.
Technical Analysis
Diagnos
―
Vitalhub
―
Rocket Doctor AI
―
Spotlite360 Technologies
―
UniDoc Health Corp
―